Skip to main content
David Miyamoto, MD, Radiation Oncology, Boston, MA

DavidT.MiyamotoMDPhD

Radiation Oncology • Boston, MA

Associate Professor of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School

Join to view full profile

Dr. Miyamoto is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Miyamoto's full profile

Already have an account?

  • Office

    55 Fruit St
    Boston, MA 02114
    Phone+1 617-726-5866
    Fax+1 617-726-3603

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2007 - 2011
  • Brigham and Women's Hospital
    Brigham and Women's HospitalInternship, Internal Medicine, 2006 - 2007
  • Harvard Medical School
    Harvard Medical SchoolClass of 2006

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2008 - 2026
  • ME State Medical License
    ME State Medical License 2020 - 2021
  • American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

Journal Articles

  • A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer  
    David T Miyamoto, Aditya Bardia, Lecia V Sequist, Laura M Spring, Daniel A Haber, Mark Kalinich, Clinical Cancer Research

Press Mentions

  • MRI-Guided SBRT Shows Sustained Benefits for Prostate Cancer
    MRI-Guided SBRT Shows Sustained Benefits for Prostate CancerOctober 4th, 2024
  • New Discovery by Massachusetts General Hospital May Help Medical Laboratories Preserve Blood for DNA Analysis, Thus Allowing Isolation of CTCs up to 72 Hours After Collection
    New Discovery by Massachusetts General Hospital May Help Medical Laboratories Preserve Blood for DNA Analysis, Thus Allowing Isolation of CTCs up to 72 Hours After CollectionJune 27th, 2018
  • Henning Willers, MD and David Miyamoto, MD, PhD Receive $150,000 Grant from Aid for Cancer Research
    Henning Willers, MD and David Miyamoto, MD, PhD Receive $150,000 Grant from Aid for Cancer ResearchMay 21st, 2018
  • Join now to see all

Dr. David Miyamoto, Dr. David Miyamoto, MD, Dr. D Miyamoto, Dr. David T. Miyamoto